Emcyt

— THERAPEUTIC CATEGORIES —
  • Prostate and other male cancers

Emcyt Generic Name & Formulations

General Description

Estramustine phosphate sodium (prodrug of estradiol) 140mg; caps.

How Supplied

Caps—100

Manufacturer

Emcyt Indications

Indications

Palliative of metastatic, progressive prostate cancer.

Emcyt Dosage and Administration

Adult

Take 1 hour before or 2 hours after meals. 14mg/kg in 3 or 4 divided doses; reevaluate after 30 to 90 days. Continue as long as favorable response maintained.

Children

Not applicable.

Emcyt Contraindications

Contraindications

Active thrombophlebitis or thromboembolic disorders (except when tumor mass caused by thromboembolic phenomenon). Allergy to estradiol, nitrogen mustard.

Emcyt Boxed Warnings

Not Applicable

Emcyt Warnings/Precautions

Warnings/Precautions

History of thrombophlebitis, thrombosis, thromboembolic disorders. Cerebro- or cardiovascular disease. Diabetes. Hypertension. Conditions aggravated by fluid retention. Renal or hepatic dysfunction. Monitor bilirubin and hepatic enzymes during and for 2 months after treatment is discontinued. Metabolic bone diseases associated with hypercalcemia. Use effective contraception.

Emcyt Pharmacokinetics

See Literature

Emcyt Interactions

Interactions

Absorption impaired by calcium.

Emcyt Adverse Reactions

Adverse Reactions

Edema, dyspnea, leg cramps; nausea, diarrhea, GI upset; pruritus, dry skin, easy bruising; breast tenderness and enlargement; lethargy, emotional lability, insomnia; leucopenia; abnormal bilirubin, LDH, SGOT. Thrombosis, MI.

Emcyt Clinical Trials

See Literature

Emcyt Note

Not Applicable

Emcyt Patient Counseling

See Literature